AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
THE EFFECT OF GENDER ON QUALITY-OF-LIFE (QOL) INSTRUMENTS IN IBD
Authors: ANAM S HANAUER S
Citation: S. Anam et S. Hanauer, THE EFFECT OF GENDER ON QUALITY-OF-LIFE (QOL) INSTRUMENTS IN IBD, Gastroenterology, 114(4), 1998, pp. 3770-3770
SAFETY, TOLERANCE AND EFFICACY OF MULTIPLE DOSES OF SUBCUTANEOUS INTERLEUKIN-10 IN MILD-TO-MODERATE ACTIVE CROHNS-DISEASE (STAMM-CD)
Authors: FEDORAK RN GANGL A ELSON CO RUTGEERTS P SCHREIBER S WILD G HANAUER S VANDEVENTER SJH GRINT P
Citation: Rn. Fedorak et al., SAFETY, TOLERANCE AND EFFICACY OF MULTIPLE DOSES OF SUBCUTANEOUS INTERLEUKIN-10 IN MILD-TO-MODERATE ACTIVE CROHNS-DISEASE (STAMM-CD), Gastroenterology, 114(4), 1998, pp. 3993-3993
HLA DISPARITY DETERMINES DISEASE-ACTIVITY THROUGH PREGNANCY IN WOMEN WITH IBD
Authors: KANE S HANAUER S KIESEL J SHIH L TYGAN D
Citation: S. Kane et al., HLA DISPARITY DETERMINES DISEASE-ACTIVITY THROUGH PREGNANCY IN WOMEN WITH IBD, Gastroenterology, 114(4), 1998, pp. 4121-4121
POSTOPERATIVE PROPHYLAXIS WITH 6-MP, 5-ASA OR PLACEBO IN CROHNS-DISEASE - A 2-YEAR MULTICENTER TRIAL
Authors: KORELITZ B HANAUER S RUTGEERTS P PRESENT D PEPPERCORN M
Citation: B. Korelitz et al., POSTOPERATIVE PROPHYLAXIS WITH 6-MP, 5-ASA OR PLACEBO IN CROHNS-DISEASE - A 2-YEAR MULTICENTER TRIAL, Gastroenterology, 114(4), 1998, pp. 4141-4141
SEGMENTAL COLITIS LIMITED TO THE SIGMOID COLON - CAN WE PREDICT THE CLINICAL COURSE BASED UPON ENDOSCOPIC AND HISTOLOGIC-FINDINGS - A LONG-TERM FOLLOW-UP-STUDY
Authors: STEIN R HART J HANAUER S
Citation: R. Stein et al., SEGMENTAL COLITIS LIMITED TO THE SIGMOID COLON - CAN WE PREDICT THE CLINICAL COURSE BASED UPON ENDOSCOPIC AND HISTOLOGIC-FINDINGS - A LONG-TERM FOLLOW-UP-STUDY, Gastroenterology, 114(4), 1998, pp. 4464-4464
LENGTH AND TYPE OF RECURRENT ILEITIS AFTER ILEAL RESECTION CORRELATE WITH PRESURGICAL FEATURES IN CROHNS-DISEASE
Authors: DHAENS G BAERT F GASPARAITIS A HANAUER S
Citation: G. Dhaens et al., LENGTH AND TYPE OF RECURRENT ILEITIS AFTER ILEAL RESECTION CORRELATE WITH PRESURGICAL FEATURES IN CROHNS-DISEASE, Inflammatory bowel diseases, 3(4), 1997, pp. 249-253
STANDARDS FOR TRIALS OF THERAPY IN INFLAMMATORY BOWEL-DISEASE
Authors: SUTHERLAND LR HANAUER S SCHOLMERICH J
Citation: Lr. Sutherland et al., STANDARDS FOR TRIALS OF THERAPY IN INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 3(4), 1997, pp. 277-283
CONTROLLED-STUDY OR ANTI-TNF-ALPHA TREATMENT FOR ENTEROCUTANEOUS FISTULAS COMPLICATING CROHNS-DISEASE
Authors: VANDEVENTER SJH VANHOGEZAND R PRESENT D HANAUER S TARGAN S DHAENS G DEWOODY K BRAAKMAN T SCHAIBLE T RUTGEERTS P
Citation: Sjh. Vandeventer et al., CONTROLLED-STUDY OR ANTI-TNF-ALPHA TREATMENT FOR ENTEROCUTANEOUS FISTULAS COMPLICATING CROHNS-DISEASE, Gut, 41, 1997, pp. 2-2
SAFETY AND ACTIVITY EVALUATION OF RHIL-11 IN SUBJECTS WITH ACTIVE CROHNS-DISEASE
Authors: BANK S SNINSKY C ROBINSON M KATZ S SINGLETON J MINER P SAFDI M GALANDIUK S HANAUER S VARILEK G SANDS B BUCHMAN A ROGERS V SALZBERG B CAI B ROGGE H SCHWERTSCHLAG U
Citation: S. Bank et al., SAFETY AND ACTIVITY EVALUATION OF RHIL-11 IN SUBJECTS WITH ACTIVE CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 927-927
COMPLICATIONS DURING CYCLOSPORINE THERAPY FOR INFLAMMATORY BOWEL-DISEASE
Authors: STEIN R COHEN R HANAUER S
Citation: R. Stein et al., COMPLICATIONS DURING CYCLOSPORINE THERAPY FOR INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 112(4), 1997, pp. 1096-1096
CYCLOSPORINE FOR SEVERE ULCERATIVE-COLITIS - A USERS GUIDE
Authors: KORNBLUTH A PRESENT DH LICHTIGER S HANAUER S
Citation: A. Kornbluth et al., CYCLOSPORINE FOR SEVERE ULCERATIVE-COLITIS - A USERS GUIDE, The American journal of gastroenterology, 92(9), 1997, pp. 1424-1428
DRUG TRIALS IN INFLAMMATORY BOWEL DISEASES 1993-1995 - A SURVEY CONDUCTED BY THE IOIBD
Authors: GOEBELL H CAMPIERI M GILAT T HANAUER S KORELITZ B LAURITSEN K MALCHOW H MARTIN F MIGLIOLI M MODIGLIANI R PRESENT D SCHOLMERICH J SUTHERLAND L
Citation: H. Goebell et al., DRUG TRIALS IN INFLAMMATORY BOWEL DISEASES 1993-1995 - A SURVEY CONDUCTED BY THE IOIBD, Inflammatory bowel diseases, 2(4), 1996, pp. 265-267
A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS
Authors: ROMANUNFER S BITRAN JD GARRISON L PROESCHEL C HANAUER S SCHROEDER L JOHNSON L KLEIN L MARTINEC J
Citation: S. Romanunfer et al., A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 24(7), 1996, pp. 823-828
TANDEM HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS YIELDS PROLONGED SURVIVAL IN STAGE-IV BREAST-CANCER
Authors: BITRAN JD SAMUELS B KLEIN L HANAUER S JOHNSON L MARTINEC J HARRIS E KEMPLER J WHITE W
Citation: Jd. Bitran et al., TANDEM HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS YIELDS PROLONGED SURVIVAL IN STAGE-IV BREAST-CANCER, Bone marrow transplantation, 17(2), 1996, pp. 157-162
APPENDECTOMY IS PROTECTIVE AGAINST THE DEVELOPMENT OF ULCERATIVE-COLITIS
Authors: TASIOPOULOS J KAVIN H GOLDMAN J WOSETH D HANAUER S
Citation: J. Tasiopoulos et al., APPENDECTOMY IS PROTECTIVE AGAINST THE DEVELOPMENT OF ULCERATIVE-COLITIS, Gastroenterology, 110(4), 1996, pp. 1026-1026
ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA FOLLOWING INTENSIVE CHEMOTHERAPY FOR BREAST-CANCER
Authors: ROMANUNFER S BITRAN JD HANAUER S JOHNSON L RITA D BOOTH C CHEN K
Citation: S. Romanunfer et al., ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA FOLLOWING INTENSIVE CHEMOTHERAPY FOR BREAST-CANCER, Bone marrow transplantation, 16(1), 1995, pp. 163-168
QUALITY-OF-LIFE RESULTS OF DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MESALAMINE IN PATIENTS WITH CROHNS-DISEASE
Authors: SINGLETON JW HANAUER S ROBINSON M
Citation: Jw. Singleton et al., QUALITY-OF-LIFE RESULTS OF DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MESALAMINE IN PATIENTS WITH CROHNS-DISEASE, Digestive diseases and sciences, 40(5), 1995, pp. 931-935
SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS
Authors: MINER P HANAUER S ROBINSON M SCHWARTZ J ARORA S BRIGGS RL LAWLIS V FELGER C KITZMILLER G LIEBERMANN T FRACHTMAN R FISCHER C CELLO JP GRENDELL J SATOW J HANAUER SB HANAN I SCHULTZ P JAMES D MERTESDORF J HIESTAND F TUCKER P ROBERTS T BRUNDAGE P GRIFFIN T BECK JE RICK G HARTONG W BUSER W BRAND S BRYANT P KLIEWER M MELLOW M MCFADDEN R NEUMANN D HELIN K PRIVETTCOINTEPAS CJ MEEK RR ROUFAIL W BRICE R HUGHES TP FINA M MURPHY D CLINARD L ALLMAN D BOWEN B SCHWARTZ JL JURCIK I WHITE LB COHEN M SALES D GOCHNOUR S YORK NM WEINBERG D DUBOW RA PRIES J TOMBERS J GILBERSTADT S HANNA P WATSON MJ MATTISON M SAFDI M SAFDI A SCHNEIDER R WAISSBLUTH G KRAINES MD MAGAW L EMRATH N KAPLAN M MCKUSICK A ROSENBERG F KIRCH EP ALLEN HA WEBER B BARRIERO MA BANK L GITCHELL L STRUM WB GOODMAN L MATTER S MILLER D ANTONSON C CHRISTIAN R BIDDLE W CLARK S SUTTON DS KATON RM SMITH F BENNER K KEEFFE E LIEBERMAN D MELNYK C LINDENBURG F WEBSTER S ZFASS A KIRBY D LEE A YEE YS GOSHGARIANPATRICK P BARISH C ASHBURN P WATERMAN DC PATTERSON PM CARLISLE WR OUTIM L TOBIAS R COCHRAN JL BRISTOW WJ MILLER PD INGLE S KERR RM CASTELL D WU WC RICHTER JE GILLIAM JH STARK G LAW R MALONE N ROI L COEN M MOORE D MCPHERSON M
Citation: P. Miner et al., SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS, Digestive diseases and sciences, 40(2), 1995, pp. 296-304
SIGMOIDITIS - A CLINICAL SYNDROME WITH A SPECTRUM OF PATHOLOGICAL FEATURES, INCLUDING A DISTINCTIVE FORM OF IBD
Authors: HART J BAERT F HANAUER S
Citation: J. Hart et al., SIGMOIDITIS - A CLINICAL SYNDROME WITH A SPECTRUM OF PATHOLOGICAL FEATURES, INCLUDING A DISTINCTIVE FORM OF IBD, Laboratory investigation, 72(1), 1995, pp. 62-62
DOSE-RANGING STUDY OF BUDESONIDE ENEMA IN ACTIVE DISTAL ULCERATIVE-COLITIS
Authors: HANAUER S ROBINSON M
Citation: S. Hanauer et M. Robinson, DOSE-RANGING STUDY OF BUDESONIDE ENEMA IN ACTIVE DISTAL ULCERATIVE-COLITIS, Gastroenterology, 108(4), 1995, pp. 832-832
SENSITIVE MARKERS OF RENAL DYSFUNCTION ARE ELEVATED IN CHRONIC ULCERATIVE-COLITIS (CUC)
Authors: SNINSKY C HANAUER S POWERS B ROBINSON M MAYLE J ELSON C DEMICCO M BUTT J PRUITT R MCHATTIE J BOZDECH J SAFDI M GURNEY M FIXELLE A WOLF D LEVIN A SMOOTS J
Citation: C. Sninsky et al., SENSITIVE MARKERS OF RENAL DYSFUNCTION ARE ELEVATED IN CHRONIC ULCERATIVE-COLITIS (CUC), Gastroenterology, 108(4), 1995, pp. 919-919
SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL
Authors: LAURSEN LS LAURITSEN K BUKHAVE K RASKMADSEN J JACOBSEN O NAESDAL J GOEBELL H PESKAR B RUBIN PD SWANSON LJ KESTERSON JW KESHAVARZIAN A KOZAREK R HANAUER S CORT D STENSON WF
Citation: Ls. Laursen et al., SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL, European journal of gastroenterology & hepatology, 6(3), 1994, pp. 209-215
MESALAMINE CAPSULES ENHANCE THE QUALITY-OF-LIFE FOR PATIENTS WITH ULCERATIVE-COLITIS
Authors: ROBINSON M HANAUER S HOOP R ZBROZEK A WILKINSON C
Citation: M. Robinson et al., MESALAMINE CAPSULES ENHANCE THE QUALITY-OF-LIFE FOR PATIENTS WITH ULCERATIVE-COLITIS, Alimentary pharmacology & therapeutics, 8(1), 1994, pp. 27-34
CYCLOSPORINE IN SEVERE ULCERATIVE-COLITIS REFRACTORY TO STEROID-THERAPY
Authors: LICHTIGER S PRESENT DH KORNBLUTH A GELERNT I BAUER J GALLER G MICHELASSI F HANAUER S
Citation: S. Lichtiger et al., CYCLOSPORINE IN SEVERE ULCERATIVE-COLITIS REFRACTORY TO STEROID-THERAPY, The New England journal of medicine, 330(26), 1994, pp. 1841-1845
CYA IN SEVERE STEROID-RESISTANT UC - LONG-TERM RESULTS OF THERAPY
Authors: BAERT F HANAUER S
Citation: F. Baert et S. Hanauer, CYA IN SEVERE STEROID-RESISTANT UC - LONG-TERM RESULTS OF THERAPY, Gastroenterology, 106(4), 1994, pp. 10000648-10000648
Risultati: 1-25 | 26-33